Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation

References

• Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338(13):853–860. doi:10.1056/NEJM1998032633813019516219
   PubMed Web of Science ®Google Scholar
• Sterne JAC, Hernán MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366(9483):378–384. doi:10.1016/S0140-6736(05)67022-516054937
   PubMed Web of Science ®Google Scholar
• Lewden C. Responders to antiretroviral treatment over 500 CD4/mm3 reach same mortality rates as general population: APRICO and Aquitaine Cohorts. 10th European Aids Conference; 11 17–20; 2005; Dublin.
   Google Scholar
• Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368(9534):505–510. doi:10.1016/S0140-6736(06)69158-716890837
   PubMed Web of Science ®Google Scholar
• Hull MW, Montaner J. Antiretroviral therapy: a key component of a comprehensive HIV prevention strategy. Curr HIV/AIDS Rep. 2011;8(2):85–93. doi:10.1007/s11904-011-0076-621445551
   PubMedGoogle Scholar
• Desai M, Iyer G, Dikshit RK. Antiretroviral drugs: critical issues and recent advances. Indian J Pharmacol. 2012;44(3):288. doi:10.4103/0253-7613.9629622701234
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413–420. doi:10.1023/A:10162128042887617530
   PubMed Web of Science ®Google Scholar
• Williams HD, Trevaskis NL, Charman SA, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65(1):315–499.23383426
   PubMed Web of Science ®Google Scholar
• Krishnaiah YSR. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J Bioequiv Availab. 2010;2(2):28–36.
   Google Scholar
• Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm. 2011;420(1):1–10. doi:10.1016/j.ijpharm.2011.08.03221884771
   PubMed Web of Science ®Google Scholar
• Hu J, Johnston KP, Williams III RO. Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm. 2004;30(3):233–245. doi:10.1081/DDC-12003042215109023
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–133. doi:10.1016/S0928-0987(01)00095-111297896
   PubMed Web of Science ®Google Scholar
• Kumar S, Bhargava D, Thakkar A, Arora S. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review. Crit Rev Ther Drug Carr Syst. 2013;30(3). doi:10.1615/CritRevTherDrugCarrierSyst.2013005964
   PubMed Web of Science ®Google Scholar
• Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability. Drug Metab Pharmacokinet. 2012;1201120342.
   Web of Science ®Google Scholar
• Urbanetz NA. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. Eur J Pharm Sci. 2006;28(1–2):67–76. doi:10.1016/j.ejps.2005.12.00916472995
   PubMedGoogle Scholar
• Sharma P, Garg S. Pure drug and polymer-based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Adv Drug Deliv Rev. 2010;62(4–5):491–502. doi:10.1016/j.addr.2009.11.01919931328
   PubMed Web of Science ®Google Scholar
• Williams GC, Sinko PJ. Oral absorption of the HIV protease inhibitors: a current update. Adv Drug Deliv Rev. 1999;39(1–3):211–238. doi:10.1016/S0169-409X(99)00027-710837775
   PubMedGoogle Scholar
• Branham ML, Moyo T, Govender T. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. Eur J Pharm Biopharm. 2012;80(1):194–202. doi:10.1016/j.ejpb.2011.08.00521906676
   PubMed Web of Science ®Google Scholar
• Hosny KM, Hassan AH. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation. Int J Pharm. 2014;475(1–2):191–197. doi:10.1016/j.ijpharm.2014.08.06425178831
   PubMedGoogle Scholar
• Al-Subaie MM, Hosny KM, El-Say KM, Ahmed TA, Aljaeid BM. Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections. Int J Nanomedicine. 2015;10:3973.26109856
   PubMed Web of Science ®Google Scholar
• Pathak SM, Musmade P, Dengle S, Karthik A, Bhat K, Udupa N. Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin—preparation and in vitro and in vivo evaluation. Eur J Pharm Sci. 2010;41(3–4):440–451. doi:10.1016/j.ejps.2010.07.01320656025
   PubMed Web of Science ®Google Scholar
• Fitzsimmons ME, Collins JM. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. Drug Metab Dispos. 1997;25(2):256–266.9029057
   PubMed Web of Science ®Google Scholar
• Eagling VA, Back DJ, Barry MG. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol. 1997;44(2):190–194. doi:10.1046/j.1365-2125.1997.00644.x9278209
   PubMed Web of Science ®Google Scholar
• Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find Exp Clin Pharmacol. 1998;20(3):211–216.9646283
   PubMedGoogle Scholar
• Agharkar S, Lindenbaum S, Higuchi T. Enhancement of solubility of drug salts by hydrophilic counterions: properties of organic salts of an antimalarial drug. J Pharm Sci. 1976;65(5):747–749. doi:10.1002/jps.2600650533932950
   PubMed Web of Science ®Google Scholar
• Amin K, Dannenfelser R, Zielinski J, Wang B. Lyophilization of polyethylene glycol mixtures. J Pharm Sci. 2004;93(9):2244–2249. doi:10.1002/jps.2013515295785
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 2007;24(1):1. doi:10.1007/s11095-006-9132-017109211
   PubMed Web of Science ®Google Scholar
• Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1–2):1–11. doi:10.1016/j.ijpharm.2006.10.04417137734
   PubMed Web of Science ®Google Scholar
• Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 1997;25(1):103–128. doi:10.1016/S0169-409X(96)00494-2
   Web of Science ®Google Scholar
• Vella S, Floridia M. Saquinavir. Clin Pharmacokinet. 1998;34(3):189–201. doi:10.2165/00003088-199834030-000029533981
   PubMed Web of Science ®Google Scholar
• Nolan D. Metabolic complications associated with HIV protease inhibitor therapy. Drugs. 2003;63(23):2555–2574. doi:10.2165/00003495-200363230-0000114636077
   PubMedGoogle Scholar
• Ahmed TA, El-Say KM, Hosny KM, Aljaeid BM. Development of optimized self-nanoemulsifying lyophilized tablets (SNELTs) to improve finasteride clinical pharmacokinetic behaviour. Drug Dev Ind Pharm. 2018;44(4):652–661. doi:10.1080/03639045.2017.140597729139305
   PubMed Web of Science ®Google Scholar
• Singh B, Bandopadhyay S, Kapil R, Singh R, Katare OP. Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carr Syst. 2009;26(5). doi:10.1615/CritRevTherDrugCarrierSyst.v26.i5.10
   Web of Science ®Google Scholar
• Khalid M, Ahmed TA, Ahmed OAA, Hosny KM, Abd-Allah FI. Self-nanoemulsifying lyophilized tablets for flash oral transmucosal delivery of vitamin K: development and clinical evaluation. J Pharm Sci. 2017;106(9):2447–2456. doi:10.1016/j.xphs.2017.01.00128087316
   PubMedGoogle Scholar
• El Maghraby GM. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces. 2010;75(2):595–600. doi:10.1016/j.colsurfb.2009.10.00319892531
   PubMed Web of Science ®Google Scholar
• Wu W, Wang Y, Que L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur J Pharm Biopharm. 2006;63(3):288–294. doi:10.1016/j.ejpb.2005.12.00516527467
   PubMed Web of Science ®Google Scholar
• Tan A, Rao S, Prestidge CA. Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharm Res. 2013;30(12):2993–3017. doi:10.1007/s11095-013-1107-323775443
   PubMed Web of Science ®Google Scholar
• Singh B, Singh S. A comprehensive computer program for the study of drug release kinetics from compressed matrices. Indian J Pharm Sci. 1998;60(6):358.
   Google Scholar
• Lionberger RA, Lee SL, Lee L, Raw A, Lawrence XY. Quality by design: concepts for ANDAs. Aaps J. 2008;10(2):268–276. doi:10.1208/s12248-008-9026-718465252
   PubMed Web of Science ®Google Scholar
• Cho C-W, Choi J-S, Shin S-C. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix. Drug Deliv. 2009;16(6):320–330. doi:10.1080/1071754090303108419606946
   PubMed Web of Science ®Google Scholar
• Ah Y-C, Choi J-K, Choi Y-K, Ki H-M, Bae J-H. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm. 2010;385(1–2):12–19. doi:10.1016/j.ijpharm.2009.10.01319833177
   PubMedGoogle Scholar
• Alexander A, Dwivedi S, Giri TK, Saraf S, Saraf S, Tripathi DK. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. J Control Release. 2012;164(1):26–40. doi:10.1016/j.jconrel.2012.09.01723064010
   PubMed Web of Science ®Google Scholar
• Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64(1):11–29. doi:10.1111/j.2042-7158.2011.01369.x22150668
   PubMed Web of Science ®Google Scholar
• Caon T, Kratz JM, Kuminek G, et al. Pharmacokinetics of saquinavir mesylate from oral self-emulsifying lipid-based delivery systems. Eur J Drug Metab Pharmacokinet. 2017;42(1):135–141. doi:10.1007/s13318-016-0321-x26846485
   PubMedGoogle Scholar
• Li L, Fang L, Xu X, Liu Y, Sun Y, He Z. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole. Biopharm Drug Dispos. 2010;31(2–3):138–149. doi:10.1002/bdd.69820140970
   PubMedGoogle Scholar
• Kotta S, Khan AW, Ansari SH, Sharma RK, Ali J. Formulation of nanoemulsion: a comparison between phase inversion composition method and high-pressure homogenization method. Drug Deliv. 2015;22(4):455–466. doi:10.3109/10717544.2013.86699224329559
   PubMed Web of Science ®Google Scholar
• Prajapati ST, Patel CG, Patel CN. Formulation and evaluation of transdermal patch of repaglinide. ISRN Pharm. 2011;2011.
   Google Scholar
• Guo RX, Fu XX, Chen JX, Zhou LX, Chen GX. Preparation and characterization of microemulsions of myricetin for improving its antiproliferative and antioxidative activities and oral bioavailability. J Agric Food Chem. 2016;64(32):6286–6294. doi:10.1021/acs.jafc.6b0218427455843
   PubMed Web of Science ®Google Scholar
• Gupta S, Moulik S. Biocompatible microemulsions and their prospective uses in drug delivery. J Pharm Sci. 2008;97(1):22–45. doi:10.1002/jps.2117717887122
   PubMed Web of Science ®Google Scholar
• Eggadi V, Ponna SK, Kankanala SR, Sheshagiri SBB, Gaddam SR. Determination of simvastatin and diltiazem in rat plasma by HPLC and pharmacokinetic studies. Int J Pharm Sci Res. 2013;21:53–56.
   Google Scholar
• Aqil M, Kamran M, Ahad A, Imam SS. Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: box–behnken design optimization and pharmacokinetic evaluation. J Mol Liq. 2016;214:238–248. doi:10.1016/j.molliq.2015.12.077
   Web of Science ®Google Scholar
• Fu XC, Wang GP, Liang WQ, Chow MSS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release. 2004;95(2):209–216. doi:10.1016/j.jconrel.2003.11.00714980769
   PubMed Web of Science ®Google Scholar
• Wahab AFA, Hussein AK, Khaled KA, Ahmed OAA. Meloxicam depot parenteral bio-degradable microspheres: preparation, characterization and in-vivo evaluation. Int J Pharm Sci Rev Res. 2013;21(2):38–45.
   Google Scholar
• Pathan IB, Setty CM. Enhancement of transdermal delivery of tamoxifen citrate using nanoemulsion vehicle. Int J Pharm Tech Res. 2011;3(1):287–297.
   Google Scholar
• Thacharodi D, Rao KP. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int J Pharm. 1994;111(3):235–240. doi:10.1016/0378-5173(94)90346-8
   Google Scholar
• Patel RP, Patel G, Patel H, Baria A. Formulation and evaluation of transdermal patch of aceclofenac. Res J Pharm Dos Forms Technol. 2009;1(2):108–115.
   Google Scholar
• Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release. 2004;98(3):427–436. doi:10.1016/j.jconrel.2004.06.00115312998
   PubMed Web of Science ®Google Scholar
• Chen H, Jin X, Li Y, Tian J. Investigation into the physical stability of a eugenol nanoemulsion in the presence of a high content of triglyceride. RSC Adv. 2016;6(93):91060–91067. doi:10.1039/C6RA16270C
   Web of Science ®Google Scholar